Brian Nowosielski

Travis Wolff, PharmD, BCACP, presents on the current landscape of medical billing in pharmacy practice and the steps pharmacists can take to realize a significantly higher profit margin.

In part 2, Sylvie Stacy, MD, MPH, explores the current evidence regarding GLP-1s for SUD, the work still necessary in the future of this space, and where pharmacists fall within it all.

Jon Grice, PharmD, MSA, vice president of pharmacy insights at Outcomes, explores the framework necessary and steps businesses must take to ensure pharmacy growth.

Event moderator Jesse McCullough, PharmD, wraps up the Total Pharmacy Solutions Summit Spring 2026 event with key takeaways and insights into the evolving road pharmacy is headed on.

Blair Thielemier, PharmD, EQUIPP customer success manager at PQS by Innovaccer, offers insight into key technology being used to realize greater revenue for pharmacy businesses.

Ketan Mehta, CEO and president of PrimeRx, presented a keynote session on helping independent pharmacies diversify purchasing, improve cash flow, and reduce the cost of goods sold.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Emily Hoffins, MS, PhD, postdoctoral researcher in the SCRPTS Lab at the University of Illinois Chicago Retzky College of Pharmacy.

Suzanne K. Higginbotham, PharmD, BCACP, CTTS, CDCES, further discusses her APhA 2026 presentation titled “Real-Time. Real Change. Rethinking CGM for Today's Patient.”

Sylvie Stacy, MD, MPH, introduces her work on GLP-1s for addiction and the new pathways this drug class can introduce for patients living with SUD.

Ashley Chinchilla, PharmD, BCACP, presents on the persistence of vaccine hesitancy among patients and the powerful tools used to address it.

Darren Mensch, PharmD, BCPS, BCACP, joins to discuss his presentation at APhA 2026 titled “Quality Wars: The AI Awakens in Pharmacy Practice.”

Stefanie Ferreri, PharmD, BCACP, FCCP, FAPhA, presents on the increase of misinformation circulating among the public and how pharmacists can combat this phenomenon.

Sally Rafie, PharmD, BCPS, dives deeper into her APhA 2026 presentation titled “Lights, Camera, Access: Contraception Care at the Pharmacy.”

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, present on updates to the ADA Standards of Care in Diabetes.

Amid recent comments from FDA Commissioner Marty Makary, MD, MPH, that “everything should be OTC,” Mark Garofoli, PharmD, BCGP, CPE, CTTS, helps pharmacists understand what lies ahead.

Gretchen Garofoli, PharmD, BCACP, CTTS, FAPhA, provides her perspective on the back-and-forth stemming from the federal government regarding US vaccine guidelines.

Gretchen Garofoli, PharmD, BCACP, CTTS, FAPhA, provides her perspectives on the federal vaccine overhaul and its recent reversal in a Massachusetts federal court.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, dives deeper into recent comments from the FDA commissioner and what they mean for OTC medication access.

In a bonus episode of the Over the Counter podcast, William A. Bryson, PharmD, joined to help celebrate Diabetes Alert Day—recognized annually on the fourth Tuesday in March.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

With efforts to further scale naloxone access in US community pharmacies, researchers explore the implementation of a hub-and-spoke distribution model.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, provides nuance and understanding to the FDA’s recent push to move, essentially, ‘every’ drug to OTC formulation.

Along with presenting best practices for pharmacies’ vaccination workflows, researchers explore the impact of community pharmacies offering technician-administered vaccines.

In an exploration of the drug stigma scale, researchers assess its ability to address factors associated with stigma levels regarding OTC misuse.

With the OPUS-1, 2, and 3 trials underway, Vax-31 has the potential to become the first pneumococcal vaccine of its kind, demonstrating never-before-seen impacts on disease burden.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Paul Weidle, PharmD, MPH, to discuss HIV care among women and girls.

Annie Lambert, PharmD, BCSCP, discusses pharmacies’ regulation and compliance needs when it comes to dispensing compounded GLP-1s.

Investigators used a large cohort of patients from Taiwan between 2004 and 2015 to determine the potential link between Tylenol use and childhood neurodevelopment.